Transcriptome analysis for KDM6A mutated urothelial bladder carcinoma and EZH2 inhibitor treated KDM6A mutated urothelial bladder carcinoma. Homo sapiens
收藏NIAID Data Ecosystem2026-03-10 收录
下载链接：
https://www.ncbi.nlm.nih.gov/bioproject/PRJNA358425
下载链接
链接失效反馈官方服务：
资源简介：
Purpose: The goals of this study are to compare 1. The transcription profile in KDM6A wildtype and KDM6A mutated urothelial bladder carcinoma. 2. The transcriptional changes in KDM6A mutated urothelial bladder carcinoma upon EZH2 inhibitor treatment. Overall design: Transcriptome profiling of KDM6A wildtype and KDM6A mutated urothelial bladder carcinoma were generated by deep sequencing, 10 cases in each group, using Hiseq2000. Transcriptome profiling of EZH2 inhibitor-treated KDM6A wildtype and KDM6A mutated urothelial bladder carcinoma were generated by deep sequencing, in triplicate, using Hiseq2000.
创建时间：
2016-12-21
